ETHARIS
TRADE | CAPITAL | EXECUTION
Integrated GMP Manufacturing, Global Supply Chains & Structured Cannabis Trade
ABOUT US
A vertically integrated medicinal cannabis platform connecting manufacturing, global supply, and patient access.
​​
The business combines GMP-compliant production and formulation with established international supply networks and multi-channel distribution, including wholesale, pharmacy, and telehealth. This integrated model enables Etharis to manage the full product lifecycle - from development and manufacturing through to patient access.
​
Etharis sources competitively priced, high-quality medicinal cannabis products directly from origin markets, including Thailand, Canada, and South Africa, supplying licensed distributors, pharmacies, and partners across Australia, the United Kingdom, and Europe.
OUR MISSION
To build a globally trusted cannabis supply and capital platform that delivers compliant, high-quality products across regulated markets while generating disciplined, repeatable returns.
​
Etharis is committed to:
-
Scientific and regulatory integrity
-
Transparent and ethical trade
-
Efficient global supply chains
-
Scalable, capital-efficient growth
OUR OPERATING CAPABILITIES
GMP Manufacturing & Distribution
Australian GMP-aligned production through CMG partnership, enabling immediate packing, formulation, and supply into pharmacies and wholesale channels.
Global Supply Chain Control
​Direct sourcing from Thailand and Canada, ensuring cost advantage, consistency, and scalable supply across multiple product formats.
Structured Trade Execution
​End-to-end execution of cross-border cannabis transactions, including logistics, compliance, documentation, and delivery into licensed markets.
Capital & Trade Finance
Deployment of secured, short-cycle capital into inventory-backed transactions with escrow control and defined return structures.
Regulatory & Market Access
​Expert navigation of TGA, EU-GMP, UK WDA, and international frameworks to enable compliant market entry and distribution.
Commercial & Distribution Strategy
Pharmacy, clinic, and wholesale channel development across Australia, UK, and Europe.
ADDITIONAL CAPABILITIES
Strain & Product Strategy
Selection and optimisation of genetics and formats aligned to medical market demand and pricing dynamics.
GMP & Operational Systems
​Implementation of SOPs, QA/QC systems, and scalable manufacturing processes across partner facilities.
Global Trade
Network
Established relationships with licensed producers, processors, and distributors across key international markets.
​Capital
Partnerships
​Alignment with strategic investors and capital providers to fund inventory, expansion, and infrastructure.
Scalable
Infrastructure Model
Capital-light approach leveraging existing GMP facilities and partners to maximise return on invested capital.
Governance & Compliance
Robust structures ensuring transparency, auditability, and regulatory alignment across all jurisdictions.
WHY ETHARIS?
Integrated Platform
End-to-end capability across manufacturing, global sourcing, and distribution.
​
GMP Manufacturing Capability
Operational production and formulation in Australia, supporting both internal brands and third-party partners.
​
Direct Global Supply Access
Established sourcing from key origin markets, enabling consistent quality and competitive pricing.
​
Multi-Channel Market Access
Distribution across wholesale, pharmacy, and telehealth channels, supporting scalable patient reach.
​
Regulatory Alignment
Built to operate within Australian and international regulatory frameworks, ensuring quality and compliance.
​
Execution-Focused
Built to deliver and scale across the full medicinal cannabis value chain.
